• Home
  • Products
  • Healthcare Professionals
  • Patients & Caregivers
  • IFUs
  • About Abbott Vascular
  • Investors & Media
  • Ethics & Compliance
  • Abbott Global

Resources For...

  • Healthcare Professionals
  • Patients & Caregivers
  • Investors
  • Job Seekers
  • Students
spacer

Spotlight

spacer Announcing the International launch of Abbott Vascular's flagship drug eluting stent system, the XIENCE V Everolimus Eluting Coronary Stent System.*
*CAUTION: XIENCE V is an investigational device. Limited by Federal (U.S.) law to investigational use only.

 

spacer Announcing HT-ADVANCE, the latest addition to Abbott Vascular's HI-TORQUE coronary guide wire product family. The HI-TORQUE ADVANCE is the first guide wire with a Drug-Eluting Stent (DES) device delivery indication.

 

Reimbursement Resource - Keep up with the latest information on coverage, coding and payment for coronary, carotid and other peripheral procedures related to Abbott Vascular devices.

Investors & Media

  • Abbott to Initiate First Study to Evaluate XIENCE™ V Everolimus Eluting Coronary Stent System in Treatment of Women with Cardiovascular Disease
  • Abbott Statement Regarding CMS’ Proposed Expansion of Coverage for Carotid Artery Stenting
  • Private-Label Version of Abbott's XIENCE™V Drug-Eluting Coronary Stent System Launches in Europe

 

View more news...

LT2922560 B


Home | Site Map | Contact Us | Privacy Policy | Terms of Use

Copyright © 2006 Abbott Laboratories. Abbott Park, Illinois, U.S.A.


Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
gipoco.com is neither affiliated with the authors of this page nor responsible for its contents. This is a safe-cache copy of the original web site.